Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 12, 2007, Pages 1873-1875

  Adán, Alfredo ^a,b   Navarro, Manuel ^a   Casaroli Marano, Ricardo P ^a   Ortiz, Santiago ^a   Molina, Juan José ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Ocular Microsurgery Institute   (Spain)

Author keywords

Bevacizumab; Choroidal neovascularization; Intravitreal; Ocular histoplasmosis

Indexed keywords

BEVACIZUMAB;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; EYE FUNDUS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INFORMED CONSENT; OCULAR HISTOPLASMOSIS; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA HEMORRHAGE; RETINA SURGERY; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; EYE INFECTIONS, FUNGAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HISTOPLASMOSIS; HUMANS; INJECTIONS; SYNDROME; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 36349029071     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0637-y     Document Type: Article

References (6)

1. Olk JR, Burgess DB, McCormick PA (1984) Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome (POHS): Visual prognosis. Ophthalmology 91:1592-1602
2. Martidis A, Miller DG, Ciulla TA, Danis RP, Moorthy RS (1999) Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization. J Ocul Pharmacol Ther 15:425-428
3. Breger AS, Conway M, del Priore LV et al (1997) Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol 115:991-996
4. Saperstein DA, Rosenfeld PJ, Bressler NM et al (2002) Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: One year results of an uncontrolled, prospective case series. Ophthalmology 109:1499-1505
5. Kwak N, Okamoto N, Wood JM, Campochiaro PA (2000) VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41:3158-3164
6. Shahar J, Avery RL, Heilweil G et al (2006) Electrophysiologic and retinal penetration studies following intarvitreal injection of bevacizumab (Avastin). Retina 26:262-269